Premium
Urticarial vasculitis after meningococcal serogroup B vaccine in a 6‐year‐old girl
Author(s) -
VelascoTamariz Virginia,
PrietoBarrios Marta,
TousRomero Fátima,
PalenciaPérez Sara Isabel,
PostigoLlorente Concepción
Publication year - 2017
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13339
Subject(s) - medicine , meningococcal disease , vasculitis , dermatology , meningococcal vaccine , adverse effect , pediatrics , immunology , disease , neisseria meningitidis , immune system , immunization , biology , bacteria , genetics
The first vaccine that shows significant potential in providing broad coverage against serogroup B meningococcal disease has recently been approved. Because of its newness, potential adverse events need to be reported. Here we report a case of urticarial vasculitis, a rare disease in children, in probable relationship with the novel vaccine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom